Vigilare Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Vigilare Wealth Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-3,644	Closed	-$230K	–	208
2021 Q1	$230K	Sell	3,644 -3,065	-46%	-$191K	0.16%	167
2020 Q4	$416K	Sell	6,709 -2,748	-29%	-$169K	0.39%	59
2020 Q3	$570K	Sell	9,457 -1,497	-14%	-$90.1K	0.59%	47
2020 Q2	$644K	Buy	+10,954	New	+$655K	0.65%	42

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Vigilare Wealth Management's BMY Position: Q2 2021 in Review

Vigilare Wealth Management sold out of Bristol-Myers Squibb (BMY) in Q2 2021, closing a stake of 3,644 shares — an estimated $230K sold.

Vigilare Wealth Management first reported a position in BMY in Q2 2020 and held it in 4 quarters. The position peaked at $644K in Q2 2020. 2,369 funds tracked by Wall St. Rank hold BMY as of Q2 2021.

Vigilare Wealth Management reported no remaining Bristol-Myers Squibb position as of Q2 2021 after selling out during the quarter.
Vigilare Wealth Management sold 3,644 Bristol-Myers Squibb shares in Q2 2021, an estimated $230K.
Vigilare Wealth Management first reported a position in Bristol-Myers Squibb in Q2 2020 and held it in 4 quarters.
Vigilare Wealth Management's Bristol-Myers Squibb position peaked at $644K in Q2 2020.
2,369 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2021.

Based on Vigilare Wealth Management's 13F filing for Q2 2021, filed 16 Jul 2021.